March 10ā€“11, 2020

2nd BD&L Summit for Life Sciences

Hyatt Centric Fisherman's Warf

San Francisco, CA

REGISTER NOW Group

FEATURED TRACKS FOR 2020

Graphic 1

Who Attends?

View past participants of our Business Development series.
Group
Graphic 2

Sign Up Today

Register early & save $400 off standard rates.
Group
Graphic 3

Sponsorship

Showcase your technologies, products & services.
Group

The 2nd BD&L Summit returns in 2020 to serve as an open forum for cross-functional business development teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements and M&A deals. This year, the conference will go one step further and provide two tracks dedicated to the Legal/Transactions and Business Development areas. 

 

WHAT TO EXPECT AT THE 2ND BD&L SUMMIT

  • New tracked program offers a selection of sessions so you can optimize your learning experience and focus on topics important to you and your company
  • Identify key business goals and map out a clear strategy for potential M&As with respect to tax inversion, consolidation, divestitures, and narrowing strategic focus to maximize portfolio value
  • Understand how to conduct a comprehensive intellectual property due diligence investigation, and how it can alter the strategy for your deal 
  • Gain valuable insight into the impact company culture can have on the success of integrating the workforce post-merger or acquisition 
VIEW THE AGENDA Group

FEATURED SPEAKERS

KARAH

Karah Parschauer

EVP, General Counsel

ULTRAGENYX

LINUS

Linus S Lin, Ph.D.

Managing Director, Chorus

ELI LILY

CHRIS

Christopher Haskell, Ph.D.

Vice President, Head Open Innovation Center ā€” North America West 

BAYER

JENNIFER

Jennifer Leeds, PH.D.

Executive Director, BD&L

NOVARTIS

OLGA

Olga Kay, J.D., PH.D.

Senior IP Counsel

ROCHE MOLECULAR SOLUTIONS

SHELDON

Sheldon L Koenig, MBA

EXECUTIVE VICE PRESIDENT AND CHIEF COMMERCIAL OFFICER

PORTOLA PHARMACEUTICALS

PHILIP

Philip Gutry

Chief Business Officer

KRONOS BIO 

JAY

Jay Parish

Chief Business Officer

VIR BIOTECHNOLOGY

WHO SHOULD ATTEND

This conference is designed for representatives from pharmaceutical, medical device and biotechnology companies with responsibilities in the following areas: 

  • Business Development/Corporate development
  • Mergers and Acquisitions
  • Licensing
  • Strategic Alliance/Alliance Management
  • Intellectual Property and Patent Counsel
  • Search and Evaluation
  • Due Diligence
  • External Innovation
  • Transactions
  • Portfolio Management
  • Scientific Assessment
  • General Counsel/Corporate Counsel
  • Legal and Regulatory Compliance
  • Regulatory Affairs
  • Research and Development
  • Clinical Medicine
  • Clinical Operations
  • Life Cycle Management

This conference is also of interest to:

  • Investment Banks
  • Private Equity Firms
  • Venture Capitalists
  • Data Room Providers
  • Due Diligence Consultants
  • Law Firms
  • Clinical Affairs and CRO Partners
  • Regulatory Affairs and Compliance Partners

2020 Sponsors